Bullfrog AI (BFRG) vs Kyntra Bio (KYNB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Bullfrog AI (BFRG) has outperformed Kyntra Bio (KYNB) over the past year, losing 58.2% versus a loss of 81.5%. Bullfrog AI is the larger company by market cap ($6.6 million vs $6.3 million), about 1.1 times the size. Kyntra Bio converts more of its revenue into profit, with a net margin of 2848.6% versus -5569.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BFRG | KYNB |
|---|---|---|
| Share price | $0.3556 | $1.56 |
| Market cap | $6.65M | $6.32M |
| 1-day change | -8.84% | -13.33% |
| YTD return | -59.73% | -82.23% |
| 1-year return | -58.21% | -81.47% |
| 5-year return | — | -99.49% |
| EPS (TTM) | $-0.41 | $-4.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $116.67K | $6.44M |
| Revenue growth (YoY) | — | -78.26% |
| Net income (latest FY) | $-6.50M | $183.45M |
| Gross margin | 18.76% | 91.37% |
| Operating margin | -5652.38% | -712.66% |
| Net margin | -5569.61% | 2848.63% |
| 52-week high | $1.96 | $10.47 |
| 52-week low | $0.35 | $1.56 |
| Distance from 52-week high | -81.86% | -85.10% |
| Analyst consensus | none | none |
| Avg. price target upside | — | +2442.95% |
| Average volume | 5.38M | 29.96K |
| Shares outstanding | 18.69M | 4.05M |
| Employees | 9 | 34 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BFRG has outperformed KYNB by 23.3 percentage points over the past year.
- Kyntra Bio is more profitable, keeping 2848.6 cents of every revenue dollar as net income versus -5569.6 cents for Bullfrog AI.
About Bullfrog AI
BFRG stock →Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 9 employees
About Kyntra Bio
KYNB stock →Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatment of metastatic castration-resistant prostate cancer and other cancers.
Health Care · Biotechnology: Pharmaceutical Preparations · 34 employees
BFRG vs KYNB FAQ
Which is bigger, Bullfrog AI or Kyntra Bio?
Bullfrog AI (BFRG) is larger, with a market capitalization of $6.65M compared with $6.32M for Kyntra Bio (KYNB).
Which stock has performed better over the past year, BFRG or KYNB?
BFRG returned -58.21% over the past 12 months, compared with -81.47% for KYNB (price return, excluding dividends). Past performance does not predict future results.
Are Bullfrog AI and Kyntra Bio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.